Determination of the Biological Activity of Enriched Serums on Healthy Volunteers After Consumption of the Kera-Diet® Ingredient

NAActive, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 18, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

May 31, 2025

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Keratin hydrolysate

The clinical study will be conducted in two phases. The first phase will aim at characterizing the metabolites present in human serum after consumption of the Kera-Diet® ingredient and at determining the overall absorption peak of the tested ingredient. The second phase will involve collecting sera enriched with metabolites at the absorption peak, following the ingestion of the ingredient. Subsequently, the final objective will be to characterize the influence of these sera enriched with metabolites of interest on the behavior of human skin cell and intestinal epithelial cell cultures.

Trial Locations (1)

Unknown

University Hospital, Clermont-Ferrand, Clermont-Ferrand

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Clinic'n'Cell

OTHER

collaborator

University Hospital, Clermont-Ferrand

OTHER

lead

BCF Life Sciences

INDUSTRY

NCT06612866 - Determination of the Biological Activity of Enriched Serums on Healthy Volunteers After Consumption of the Kera-Diet® Ingredient | Biotech Hunter | Biotech Hunter